Xenon Pharmaceuticals Inc. | Company Profile - Revenue, Headcount, Tech Stack, Contacts
Industry & Market
No industry information available
Funding Information
No funding information available
Headcount Distribution
No headcount data available
Department Breakdown
No department data available
Keywords & Focus Areas
No keywords available
Overview
Xenon Pharmaceuticals Inc. is a biopharmaceutical company based in Burnaby, British Columbia, focused on developing innovative therapeutics for neurological and psychiatric disorders. Founded in 1996, the company specializes in ion channel science, particularly targeting potassium and sodium channels to address conditions such as epilepsy, major depressive disorder, bipolar depression, and pain. It is publicly traded on NASDAQ under the ticker XENE.
The company's pipeline includes azetukalner, a Kv7 potassium channel opener currently in Phase 3 trials for epilepsy and mood disorders. Additionally, it is developing NBI-921352, a sodium channel inhibitor in Phase 1 trials for epilepsy, in collaboration with Neurocrine Biosciences. Xenon also has multiple early-stage programs targeting pain treatment, advancing its clinical trials and research initiatives in neuroscience.
Key Metrics
Get Complete Company Metrics
Dive deeper into employee structure, funding, revenue, and key performance indicators all in one place.
Contact
Technology Stack
Analytics & Tracking
Social & Marketing
Database & Backend
Cloud & Infrastructure
Productivity
Compare similar companies to
Compare insights from companies similar to , focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
| Company Name | Revenue | No. of Employees | Type | Funding | Founded In | Top Executive |
|---|---|---|---|---|---|---|
| xxxxxxx | $59860 | 71 | Private | - | 3898 | x |
| x | $41460 | 121 | Private | - | 6026 | xxxxxxxxxx |
| xxxxxxx | $10043 | 5 | Private | - | 3126 | xxxxxx |
| xxxxxxxxxx | $90237 | 114 | Private | - | 4555 | xxxxxxxx |
| xxxxxxxx | $93336 | 135 | Private | - | 4154 | xx |
Discover Similar Companies Instantly
Explore detailed insights and analysis on companies related to your search.